The prostate cancer drug market

Nat Rev Drug Discov. 2021 Sep;20(9):663-664. doi: 10.1038/d41573-021-00111-w.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / pharmacology
  • Drug Development*
  • Humans
  • Male
  • Prognosis
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Survival Rate

Substances

  • Antineoplastic Agents